sulfaphenazole has been researched along with Vascular Diseases in 1 studies
Sulfaphenazole: A sulfonilamide anti-infective agent.
sulfaphenazole : A sulfonamide that is sulfanilamide in which the sulfonamide nitrogen is substituted by a 1-phenyl-1H-pyrazol-5-yl group. It is a selective inhibitor of cytochrome P450 (CYP) 2C9 isozyme, and antibacterial agent.
Vascular Diseases: Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulfaphenazole treatment significantly reduced superoxide production in arterial walls following I/R injury." | 1.33 | Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction. ( Bai, N; Granville, DJ; Hunter, AL; Laher, I, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hunter, AL | 1 |
| Bai, N | 1 |
| Laher, I | 1 |
| Granville, DJ | 1 |
1 other study available for sulfaphenazole and Vascular Diseases
| Article | Year |
|---|---|
Cytochrome p450 2C inhibition reduces post-ischemic vascular dysfunction.
Topics: Animals; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Cytochrome P450 Family | 2005 |